BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND PTEN, MMAC1, 5728, MGC11227, PTEN1, MHAM, P60484, BZS, ENSG00000171862 AND Clinical Outcome
13 results:

  • 1. pten Deficiency in Tubo-ovarian High-Grade Serous Carcinoma is Associated with Poor Progression-Free Survival and is Mutually Exclusive with CCNE1 Amplification.
    Zhang X; Wang A; Han L; Liang B; Allard G; Diver E; Howitt BE
    Mod Pathol; 2023 May; 36(5):100106. PubMed ID: 36805789
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. clinical impact of genetic alterations of CTNNB1 in patients with grade 3 endometrial endometrioid carcinoma.
    Kobayashi Kato M; Asami Y; Takayanagi D; Matsuda M; Shimada Y; Hiranuma K; Kuno I; Komatsu M; Hamamoto R; Matsumoto K; Ishikawa M; Kohno T; Kato T; Shiraishi K; Yoshida H
    Cancer Sci; 2022 May; 113(5):1712-1721. PubMed ID: 35278272
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome.
    Hollis RL; Thomson JP; Stanley B; Churchman M; Meynert AM; Rye T; Bartos C; Iida Y; Croy I; Mackean M; Nussey F; Okamoto A; Semple CA; Gourley C; Herrington CS
    Nat Commun; 2020 Oct; 11(1):4995. PubMed ID: 33020491
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Corded and Hyalinized Endometrioid Adenocarcinoma (CHEC) of the Uterine Corpus are Characterized by CTNNB1 Mutations and Can Show Adverse clinical outcomes.
    Ladwig NR; Umetsu SE; Zaloudek C; Rabban J; Garg K
    Int J Gynecol Pathol; 2021 Mar; 40(2):103-115. PubMed ID: 32909971
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Genomic Features of Metastatic Testicular Sex Cord Stromal Tumors.
    Necchi A; Bratslavsky G; Shapiro O; Elvin JA; Vergilio JA; Killian JK; Ngo N; Ramkissoon S; Severson E; Hemmerich AC; Ali SM; Chung JH; Reddy P; Miller VA; Schrock AB; Gay LM; Ross JS; Jacob JM
    Eur Urol Focus; 2019 Sep; 5(5):748-755. PubMed ID: 31147264
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. STAT3 regulated
    Jin P; Liu Y; Wang R
    Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 30061175
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Mutation profile and clinical outcome of mixed endometrioid-serous endometrial carcinomas are different from that of pure endometrioid or serous carcinomas.
    Coenegrachts L; Garcia-Dios DA; Depreeuw J; Santacana M; Gatius S; Zikan M; Moerman P; Verbist L; Lambrechts D; Matias-Guiu X; Amant F
    Virchows Arch; 2015 Apr; 466(4):415-22. PubMed ID: 25677978
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. PIK3R1 (p85α) is somatically mutated at high frequency in primary endometrial cancer.
    Urick ME; Rudd ML; Godwin AK; Sgroi D; Merino M; Bell DW
    Cancer Res; 2011 Jun; 71(12):4061-7. PubMed ID: 21478295
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Tissue and serum biomarkers as prognostic variables in endometrioid-type endometrial cancer.
    Gadducci A; Cosio S; Genazzani AR
    Crit Rev Oncol Hematol; 2011 Nov; 80(2):181-92. PubMed ID: 21134766
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Pharmaco(epi)genomics in ovarian cancer.
    Paige AJ; Brown R
    Pharmacogenomics; 2008 Dec; 9(12):1825-34. PubMed ID: 19072641
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Novel molecular profiles of endometrial cancer-new light through old windows.
    Doll A; Abal M; Rigau M; Monge M; Gonzalez M; Demajo S; Colás E; Llauradó M; Alazzouzi H; Planagumá J; Lohmann MA; Garcia J; Castellvi S; Ramon y Cajal J; Gil-Moreno A; Xercavins J; Alameda F; Reventós J
    J Steroid Biochem Mol Biol; 2008 Feb; 108(3-5):221-9. PubMed ID: 18061438
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Molecular pathology of endometrial carcinoma: transcriptional signature in endometrioid tumors.
    Abal M; Planaguma J; Gil-Moreno A; Monge M; Gonzalez M; Baro T; Garcia A; Castellvi J; Ramon Y Cajal S; Xercavins J; Alameda F; Reventos J
    Histol Histopathol; 2006 Feb; 21(2):197-204. PubMed ID: 16329044
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Synchronous endometrioid carcinomas of the uterine corpus and ovary: alterations in the beta-catenin (CTNNB1) pathway are associated with independent primary tumors and favorable prognosis.
    Irving JA; Catasús L; Gallardo A; Bussaglia E; Romero M; Matias-Guiu X; Prat J
    Hum Pathol; 2005 Jun; 36(6):605-19. PubMed ID: 16021566
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.